VentriPoint Diagnostics (TSXV:VPT) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Dec. 15, 2024)

View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate falls into.

VentriPoint Diagnostics (TSXV:VPT) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

VentriPoint Diagnostics Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

VPTDF:USA 5V7:Germany

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Executives

Hugh Macnaught	Director, Senior Officer
Robert Hodgkinson	Director
George Adams	Director, Senior Officer

VentriPoint Diagnostics Headlines

No Headlines